Page 833 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

INDEX INDEX 789

Pilocarpine, 240, 552 Platelet-derived growth factor Polycythemia, 434 Schistosoma spp, 161
Pilocytic astrocytoma, 528 (PDGF) blood oxygen in, 666 serum markers for, 390
Pilus, 124 in wound healing, 216 Eisenmenger syndrome, 299 varices and, 365
Pimozide, 572 signaling pathways for, 337 ESR in, 214 Portal triad, 361, 367
Pindolol, 245, 319 Platelet disorders, 426, 427 paraneoplastic syndromes, 228 Portal vein, 361, 367
Pineal gland, 504 transfusion for, 429 Polycythemia vera, 433 in fetal circulation, 282
Pinealoma, 528 Platysma muscle, 620 Budd-Chiari syndrome and, 392 Portosystemic anastomoses, 365
Pinworms, 159 Pleiotropy, 56 hepatocellular carcinoma, 392 Positive predictive value (PPV), 257,
Pioglitazone, 353 Pleomorphic adenomas, 376 Polydactyly, 63 259
Piperacillin Pleural effusion, 681 Polydipsia, 346 Positive punishment (aversive
characteristics of, 188 asbestosis, 677 Polyhydramnios, 491, 641 stimulus), 554
Pseudomonas aeruginosa, 143 lung cancer, 684 esophageal atresia and, 359 Positive reinforcement, 554
Piroxicam, 486 mesothelioma, 678 Polymerase chain reaction (PCR), 52 Positive skew distribution, 262
Pisiform bone, 449 physical findings, 680 Polymorphic ventricular tachycardia, Posterior cerebral artery, 502, 515
Pitting edema, 309 Pleuritis, 466 294 Posterior circulation strokes, 514
Pituitary adenoma, 339, 527 Pleuroperitoneal membrane, 370 Polymyalgia rheumatica, 470 Posterior circumflex artery, 455
Pituitary apoplexy, 339 Plicae circulares, 362 ESR in, 214 Posterior communicating artery
Pituitary drugs, 354 Plummer-Vinson syndrome, 377, 418 giant cell arteritis and, 314 in saccular aneurysm, 516
Pituitary gland, 327 Pneumatosis intestinalis, 386 Polymyositis Posterior cruciate ligament (PCL)
Pituitary prolactinomas, 328 Pneumococcal vaccine, 127 autoantibody, 115 injury, 454
Pituitary tumors Pneumoconioses, 675, 677 Polymyositis/dermatomyositis, 471 Posterior descending artery (PDA),
diabetes insipidus, 338 Pneumocystis jirovecii, 154 Polymyxin B, 143, 193, 198 283
MEN 1 and, 351 dapsone, 194 Polymyxins, 198 Posterior drawer sign, 454
Pityriasis rosea, 482 fluorescent antibody stain, 125 mechanism and use, 193 Posterior fossa
Pityrosporum spp, 152 HIV-positive adults, 177 Polyneuritis, 66 malformations, 492
pKa, 233 immunocompromised patients, 179 Polyneuropathy, 425 Posterior hypothalamus, 498
PKD genes prophylaxis, 198 familial amyloid, 212 Posterior inferior cerebellar artery
renal cyst disorders and, 604 silver stain for, 125 Polyomaviruses stroke effects, 514
Placebo, 256 TMP-SMX, 194 characteristics of, 164 Posterior malleolus, 455
Placenta Pneumocytes, 661 DNA viruses, 163 Posterior pituitary gland, 327
estrogen production, 630 Pneumomediastinum, 672 genome, 163 Posterior tibial artery, 455
fetal component, 617 Pneumonia, 683 naked viruses, 163 Posterior urethral valves, 579
hormone secretion by, 633 acute respiratory distress syndrome, Polyostotic fibrous dysplasia, 57 Postherpetic neuralgia, 165
maternal component, 617 678 Polyposis syndromes, 387 Postinfectious encephalomyelitis, 524
progesterone production, 630 adenovirus, 164 Polyps Postoperative ileus, 240
Placenta accreta/increta/percreta, 640 chlamydiae, 148 adenomatous, 387 Postpartum hemorrhage, 641
Placental aromatase deficiency, 639 coccidioidomycosis, 151 APC gene, 387 Postpartum mood disturbances, 562
Placental insufficiency common causes, 179 colonic, 387 Postpartum psychosis, 562
oligohydramnios and, 641 Haemophilus influenzae, 142 hyperplastic, 387 Postpartum thyroiditis, 341
Potter sequence, 578 measles-associated death, 170 inflammatory pseudopolyps, 387 Postprandial pain, 363
preeclampsia, 643 Pneumocystis jirovecii, 154 KRAS gene, 387 Postrenal azotemia, 601
Placenta previa, 640 PPI adverse effects, 399 mucosal, 387 Poststreptococcal glomerulonephritis
Plague, 149 Q fever, 150 nasal (cystic fibrosis), 60 (acute), 596
Plantar aponeurosis, 461 readmissions with, 272 neoplastic transformation of, 387 Post-traumatic stress disorder
Plantar fasciitis, 461 Staphylococcus aureus, 135 non-neoplastic, 387 (PTSD)
Plantar flexion, 453 Streptococcus pneumoniae, 136 serrated, 387 acute stress disorder, 564
Plantaris, 453 Streptococcus agalactiae, 137 submucosal, 387 diagnostic criteria/treatment, 564
Plantar reflex, 510 VZV, 165 uterine, 650 dissociative identity disorder, 558
Plaques (skin), 475 Pneumoperitoneum, 380 Polysaccharide capsule antigens drug therapy for, 572
actinic keratosis, 482 Pneumothorax, 680, 682 carrier proteins with, 127 prazosin for, 244
basal cell carcinoma, 484 Podocytes Polyuria SSRIs for, 575
hairy leukoplakia, 479 glomerular filtration barrier and, diabetes insipidus, 338 venlafaxine, 575
lichen planus, 482 581, 595 diabetes mellitus, 346 Postural hypotension
pityriasis rosea, 482 Poikilocytosis, 407 hyperparathyroidism, 345 midodrine for, 242
psoriasis, 477 Point of service plan, 271 lithium, 574 trazodone, 576
seborrheic dermatitis, 476 pol gene, 175 Pompe disease, 87 Postviral infections, 179
squamous cell carcinoma, 484 Poliomyelitis, 531 Pons Potassium
Plasma cell dyscrasias, 431 restrictive lung disease, 675 cranial nerve nuclei of, 505 amphotericin B, 199
Plasma cells, 409 Poliovirus, 531 development of, 490 in cardiac muscle, 292
Plasmalogens, 47 immunodeficient patients, 118 Pontiac fever, 143 diabetic ketoacidosis, 347
Plasma membrane medical importance, 167 Pontine syndrome, 514 shifts in, 590
sodium-potassium pump, 49 picornavirus, 168 “Pope’s blessing” (median nerve torsades de pointes and, 294
structure of, 49 unvaccinated children, 186 injury), 451 Potassium channel blockers, 323
Plasma osmolality Polyadenylation signal, 41 Popliteal artery, 455 Potassium channels
DI treatment, 338 Polyangiitis, microscopic atherosclerosis in, 302 myocardial action potential, 292
Plasmapheresis, 524, 596 autoantibody, 115 Popliteal fossa, 455 opioid effect, 551
Plasma protein concentration, 583 Polyarteritis nodosa, 173, 314 Popliteus, 453 Potassium chloride, 249
Plasma volume measurement, 581 Polyarthralgias Porcelain gallbladder, 396, 397 Potassium iodide
Plasminogen, 437 gonococcal arthritis, 468 Porphobilinogen deaminase, 425 Sporothrix schenckii, 154
Plasmodium spp rubella, 182 Porphyria, 425, 546 for thyroid storm, 342
chloroquine, 200 Polycystic disease (kidney), 604 Porphyria cutanea tarda, 425 Potassium-sparing diuretics, 609
Plasmodium falciparum, 157, 200 Polycystic ovarian syndrome (PCOS), Portal hypertension Potency of drugs
Plasmodium malariae, 157 645 ARPKD, 604 vs efficacy, 233
Plasmodium ovale, 157 anovulation, 645 cirrhosis and, 389 Potentiation
Plasmodium vivax, 157 antiandrogens, 658 pulmonary arterial hypertension, of drugs, 235
Platelet-activating factor, 406 clomiphene, 656 679 Pott disease, 180

FAS1_2019_21_Index_749-806.indd 789 11/21/19 12:27 PM